Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Zastrzyk życia
  • Obniżka
  • Nowy
Rheumatic Immune-Related Adverse Events, An Issue of Rheumatic Disease Clinics of North America

Rheumatic Immune-Related Adverse Events, An Issue of Rheumatic Disease Clinics of North America

9780443294006
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
569,47 zł
484,05 zł Zniżka 85,42 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 484,05 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Rheumatic Disease Clinics, guest editors Drs. Alexa Simon Meara and David Liew bring their considerable expertise to the topic of Rheumatic Immune-Related Adverse Events. Immune checkpoint inhibitors sometimes cause rheumatic-disease-like symptoms, or rheumatic immune-related adverse events (irAEs). In this issue, top experts discuss the utility of laboratory investigations for rheumatic irAEs; the future of biomarkers in rheumatic irAEs; integrating rheumatic irAE research and care into an oncological milieu; patient voices in rheumatic irAE care and research; polymyalgia rheumatica irAEs; inflammatory arthritis irAEs:: current approaches to management; and more.
Szczegóły produktu
Elsevier
100414
9780443294006
9780443294006

Opis

Rok wydania
2025
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
152 x 229
Waga (g)
510
  • Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression
    Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
    The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events
    The Current and Future of Biomarkers of Immune Related Adverse Events
    Immunotherapy Toxicity Management in Clinical Practice: Building the Clinical Infrastructure for Immune-related Adverse Event Evaluation and Care
    Patient Voices in Rheumatic Immune-related Adverse Events
    Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica
    Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management
    Immune Checkpoint Inhibitor-induced Myositis
    Immune Checkpoint Inhibitor-induced Sicca Syndrome
    De novo Connective Tissue Disorders as Immune-related Adverse Events
    Imaging in Rheumatic Immune-related Adverse Events
    The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review
    Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease[1]Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów